- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07743775
CT-Free Electromagnetic Navigation Percutaneous Localization for Pulmonary Nodules Undergoing Sublobar Resection
Clinical Evaluation of CT-Free Electromagnetic Navigation Percutaneous Localization System for Pulmonary Nodules Undergoing Sublobar Resection: A Multicenter Observational Cohort Study
Pulmonary nodules, particularly small and non-palpable nodules, present challenges for accurate localization during sublobar lung resection. This multicenter observational cohort study evaluated the feasibility, accuracy, and safety of CT-Free electromagnetic navigation percutaneous localization for pulmonary nodules requiring sublobar resection.
Patients who underwent CT-Free electromagnetic navigation localization were compared with patients who received conventional CT-guided localization. The primary outcome was localization success rate, defined as the distance between the localization marker and the pulmonary nodule center being within 10 mm.
Secondary outcomes included localization procedure time, conversion rate to other localization methods, surgical success rate, perioperative complications, postoperative hospitalization duration, and medical resource utilization.
Studieoversikt
Status
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
Jiangsu
-
Nantong, Jiangsu, Kina
- Nantong First People's Hospital
-
Nantong, Jiangsu, Kina
- Nantong Sixth People's Hospital
-
Nantong, Jiangsu, Kina
- Nantong University Affiliated Hospital
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
- Eldre voksen
Tar imot friske frivillige
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
- Adults aged 18 years or older.
- Patients with pulmonary nodules requiring sublobar resection.
- Non-palpable pulmonary nodules requiring preoperative localization.
- Patients undergoing CT-Free electromagnetic navigation localization or CT-guided localization.
Exclusion Criteria:
- Central pulmonary nodules unsuitable for localization.
- Patients unable to undergo sublobar resection.
- Patients with severe cardiopulmonary dysfunction or major organ dysfunction.
- Pregnancy or breastfeeding.
- Patients participating in other clinical trials.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
|---|
|
CT-Free Electromagnetic Navigation Localization
Patients receiving CT-Free electromagnetic navigation percutaneous localization before sublobar resection for pulmonary nodules.
|
|
CT-Guided Localization
Patients receiving conventional CT-guided localization before sublobar resection for pulmonary nodules.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Proportion of Participants With Successful Localization Based on Marker-to-Nodule Distance ≤10 mm
Tidsramme: Immediately after surgical resection
|
The proportion of participants with successful pulmonary nodule localization, defined as a distance between the localization marker and the pulmonary nodule center of ≤10 mm, measured by postoperative pathological specimen evaluation.
|
Immediately after surgical resection
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Proportion of Participants Requiring Additional Localization Procedures
Tidsramme: During surgery
|
The proportion of participants requiring additional localization methods because of unsuccessful or inaccurate initial localization.
|
During surgery
|
|
Number of Participants With Procedure-Related Complications
Tidsramme: Within 30 days after surgery
|
Procedure-related complications including pneumothorax, pulmonary hemorrhage, and infection occurring after localization and surgery.
|
Within 30 days after surgery
|
|
Duration of Pulmonary Nodule Localization Procedure
Tidsramme: From initiation to completion of the localization procedure
|
The duration from initiation of localization preparation to completion of marker placement.
|
From initiation to completion of the localization procedure
|
|
Mean Distance Between Localization Marker and Pulmonary Nodule Center (mm)
Tidsramme: Immediately after surgical specimen resection
|
The mean distance between the localization marker and the pulmonary nodule center measured immediately after surgical specimen resection.
|
Immediately after surgical specimen resection
|
|
Mean Duration of Postoperative Hospital Stay
Tidsramme: Up to 30 days after surgical resection
|
The mean duration of hospitalization after surgical resection, calculated from the date of surgery to the date of hospital discharge.
|
Up to 30 days after surgical resection
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 2025-K079
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .